MY Morning Wrap | MAHB Confirms Getting Privatisation Offer from Consortium Led by Khazanah
Stocks to watch: MAHB, Axiata, MyEG.
Astellas Pharma Inc. (ALPMF) Q2 2023 Earnings Call Transcript Summary
The following is a summary of the Astellas Pharma Inc. (ALPMF) Q2 2023 Earnings Call Transcript:Financial Performance:Astellas Pharma reported a revenue decrease of 2% YoY due to Lexiscan generics' im
Biden's Million Dollar Moonshot - $240 Million Is A Boon For Cancer Research, Will It Be a Boost For Pharma Stocks Too?
In September, Biden unveiled a $240 million investment to combat cancer, augmenting the administration's "Cancer Moonshot", an initiative with an array of new health resources. The funding, allocated
Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties
Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties
Analyst Expectations for Marinus Pharma's Future
Over the past 3 months, 5 analysts have published their opinion on Marinus Pharma (NASDAQ:MRNS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a
Marinus Pharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/05/2023 260% HC Wainwright & Co. → $27 Reiterates Buy → Buy 11/08/2023 233.33% Truist Securities $32 →